A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes

NCT00111631 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

218

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus Type 2

Interventions

DRUG: DPP-IV Inhibitor
DRUG: Metformin
DRUG: Placebo

Sponsor

Hoffmann-La Roche